Clinical Trial Update: A Crossover Study of Patients with HF to Compare Natriuretic Effects of IR Torsemide Vs. ER Torsemide Over 12 Hrs [Phase 4]

View source ↗

Summary

A Phase 4 crossover trial in heart failure patients comparing the natriuretic effects of immediate-release torsemide versus extended-release torsemide over 12 h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Torsemide (extended-release) (torsemide)
• Torsemide (immediate-release) (torsemide)

Snippet

Sponsor: Sarfez Pharmaceuticals, Inc. | Conditions: Heart Failure | Phase 4 | Status: TERMINATED